Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | EXP | | 6480464 | o and p'-DDT results in increased expression of MAGED1 mRNA | CTD | PMID:24096037 | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | Maged1 (Mus musculus) | 6480464 | o and p'-DDT results in increased expression of MAGED1 mRNA | CTD | PMID:24096037 | 1,2-dimethylhydrazine | multiple interactions | ISO | Maged1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAGED1 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Maged1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGED1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Maged1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGED1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAGED1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Maged1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAGED1 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of MAGED1 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of MAGED1 mRNA | CTD | PMID:21346803 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Maged1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of MAGED1 mRNA | CTD | PMID:28973697 | 5-fluorouracil | affects response to substance | ISO | MAGED1 (Homo sapiens) | 6480464 | MAGED1 protein affects the susceptibility to Fluorouracil | CTD | PMID:15548681 and PMID:16217747 | acrylamide | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of MAGED1 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of MAGED1 mRNA | CTD | PMID:27153756 | aflatoxin B1 | increases methylation | ISO | MAGED1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MAGED1 exon | CTD | PMID:30157460 | aflatoxin B1 | decreases methylation | ISO | MAGED1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of MAGED1 gene and Aflatoxin B1 results in decreased methylation of MAGED1 intron | CTD | PMID:27153756 and PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | MAGED1 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of MAGED1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MAGED1 mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MAGED1 mRNA | CTD | PMID:16483693 | aristolochic acid A | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MAGED1 mRNA | CTD | PMID:33212167 | azathioprine | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of MAGED1 mRNA | CTD | PMID:22623647 | Benoxacor | decreases expression | ISO | Maged1 (Mus musculus) | 6480464 | benoxacor results in decreased expression of MAGED1 mRNA | CTD | PMID:34850242 | benzo[a]pyrene | decreases expression | ISO | Maged1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MAGED1 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | affects methylation | ISO | MAGED1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MAGED1 5' UTR and Benzo(a)pyrene affects the methylation of MAGED1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MAGED1 mRNA | CTD | PMID:21632981 and PMID:26238291 | benzo[e]pyrene | increases methylation | ISO | MAGED1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of MAGED1 intron | CTD | PMID:30157460 | beta-naphthoflavone | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of MAGED1 mRNA | CTD | PMID:32858204 | bisphenol A | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MAGED1 mRNA | CTD | PMID:25912373 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MAGED1 mRNA | CTD | PMID:34947998 | bisphenol A | affects expression | ISO | MAGED1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of MAGED1 mRNA | CTD | PMID:30903817 | carbon nanotube | decreases expression | ISO | Maged1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of MAGED1 mRNA | CTD | PMID:25554681 | chloropicrin | increases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | chloropicrin results in increased expression of MAGED1 mRNA | CTD | PMID:26352163 | choline | multiple interactions | ISO | Maged1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAGED1 gene | CTD | PMID:20938992 | cisplatin | multiple interactions | ISO | MAGED1 (Homo sapiens) | 6480464 | Cisplatin promotes the reaction [jinfukang results in increased expression of MAGED1 mRNA] and jinfukang promotes the reaction [Cisplatin results in increased expression of MAGED1 mRNA] | CTD | PMID:27392435 | cisplatin | increases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of MAGED1 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of MAGED1 mRNA | CTD | PMID:19320972 and PMID:19376846 | cocaine | affects expression | ISO | Maged1 (Mus musculus) | 6480464 | Cocaine affects the expression of MAGED1 mRNA | CTD | PMID:15681117 | columbamine | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | columbamine results in decreased expression of MAGED1 mRNA | CTD | PMID:23124089 | copper(II) sulfate | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MAGED1 mRNA | CTD | PMID:19549813 | cyclophosphamide | affects response to substance | ISO | MAGED1 (Homo sapiens) | 6480464 | MAGED1 protein affects the susceptibility to Cyclophosphamide | CTD | PMID:16217747 | cyclosporin A | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MAGED1 mRNA | CTD | PMID:20106945 more ... | dexamethasone | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of MAGED1 mRNA | CTD | PMID:25047013 | dicrotophos | increases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of MAGED1 mRNA | CTD | PMID:28302478 | disodium selenite | increases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of MAGED1 mRNA | CTD | PMID:18175754 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of MAGED1 mRNA | CTD | PMID:29391264 | ethanol | multiple interactions | ISO | Maged1 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of MAGED1 mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | Maged1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of MAGED1 mRNA | CTD | PMID:34813904 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MAGED1 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Maged1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | decreases expression | ISO | Maged1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of MAGED1 mRNA | CTD | PMID:25629700 | FR900359 | increases phosphorylation | ISO | MAGED1 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of MAGED1 protein | CTD | PMID:37730182 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MAGED1 mRNA | CTD | PMID:22061828 | L-methionine | multiple interactions | ISO | Maged1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAGED1 gene | CTD | PMID:20938992 | menadione | affects expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of MAGED1 mRNA | CTD | PMID:20044591 | methapyrilene | increases methylation | ISO | MAGED1 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of MAGED1 intron | CTD | PMID:30157460 | methotrexate | affects response to substance | ISO | MAGED1 (Homo sapiens) | 6480464 | MAGED1 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | microcystin-LR | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | cyanoginosin LR results in decreased expression of MAGED1 mRNA | CTD | PMID:29518473 | mitoxantrone | affects response to substance | ISO | MAGED1 (Homo sapiens) | 6480464 | MAGED1 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of MAGED1 mRNA | CTD | PMID:25729387 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of MAGED1 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | Maged1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MAGED1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MAGED1 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MAGED1 mRNA | CTD | PMID:29067470 | phenobarbital | affects expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of MAGED1 mRNA | CTD | PMID:19159669 | pirinixic acid | multiple interactions | ISO | MAGED1 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAGED1 mRNA | CTD | PMID:19710929 | quercetin | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of MAGED1 mRNA | CTD | PMID:21632981 | silicon dioxide | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of MAGED1 mRNA | CTD | PMID:25895662 | testosterone | decreases expression | ISO | Maged1 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of MAGED1 mRNA | CTD | PMID:33848595 | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of MAGED1 protein | CTD | PMID:35544339 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of MAGED1 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of MAGED1 mRNA | CTD | PMID:25729387 | topotecan | affects response to substance | ISO | MAGED1 (Homo sapiens) | 6480464 | MAGED1 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | valproic acid | increases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MAGED1 mRNA | CTD | PMID:23179753 | valproic acid | decreases expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MAGED1 mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | MAGED1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MAGED1 mRNA | CTD | PMID:25979313 | |